Aller au contenu
debya
Français
Se connecter Inscription gratuite
Voir sur Bluesky Suivre ce compte

Sara

@saratacotruck.bsky.social did:plc:wrtyfhm76ydut2ybvddxhpmz

Product Design Manager at Quartzy. Mom, amateur wine sob, sometimes decent cook. Herder of cats, a dog, and a few bunnies.

Sur Bluesky depuis le

Abonnés
345
Abonnements
818
Posts
308
Jours dans les classements
0

Résumé

Sara (@saratacotruck.bsky.social) est sur Bluesky depuis le 7 novembre 2024. Le compte a 345 abonnés, suit 818 comptes et a publié 308 posts.

Présence dans les classements

Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.

Ce compte n’est encore apparu dans aucun classement quotidien.

Posts aimés récemment

J’aime publics du réseau Bluesky.

  • House Judiciary Dems@democrats-judiciary.house.gov

    @slate.com on our new Epstein-Trump Report: “The report is stunning. While many of the accusations were previously publicized, the stories have been a drip-drip of allegations; putting them all together in a single report has the effect of connecting a network of abusers,

    Voir le post
  • Anna E. Cook@annaecook.com

    My skin is clear, my AI bubble is popping, and my enemies are losing elections. techcrunch.com/2026/11/02/e...

    Voir le post
  • Guardian US@us.theguardian.com

    "We cannot allow more billionaires – or trillionaires – to be made in this country, further expanding the inequality chasm that’s turning a dignified life into a luxury in this country," write @naomiaklein.bsky.social and @ilanaglazer.com.

    Voir le post
  • Erin Reed@erininthemorning.com

    Yesterday, in a hostile 60 Minutes interview with a Bari Weiss acolyte who once called trans kids a “social contagion,” El-Sayed refused to budge on trans rights. “A failure to show up and fight for that right is a failure to show up and fight for your own.” Subscribe to support our journalism.

    Voir le post
  • Chise@sailorrooscout.bsky.social

    GOOD NEWS! A personalized mRNA vaccine, known as mRNA-1457, has SUCCEEDED in keeping melanoma, a deadly skin cancer, from returning. Phase III clinical trial results in MORE THAN 1,100 patients shows the vaccine SIGNIFICANTLY cut the risk of death OR recurrence of melanoma by ALMOST HALF.

    Voir le post

Connectez-vous pour en voir plus

Comptes bloqués

Sur Bluesky, les blocages sont publics.